Export 5 results:
Author Title [ Type(Desc)] Year
Filters: Author is Jelstrom, Eve  [Clear All Filters]
Journal Article
D. S. Carrell, Cronkite, D. J., Shea, M., Oliver, M., Luce, C., Matson, T. E., Bobb, J. F., Hsu, C., Binswanger, I. A., Browne, K. C., Saxon, A. J., McCormack, J., Jelstrom, E., Ghitza, U. E., Campbell, C. I., Bradley, K. A., and Lapham, G. T., Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods., Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
T. P Korthuis, Cook, R. R., Lum, P. J., Waddell, E. Needham, Tookes, H., Vergara-Rodriguez, P., Kunkel, L. E., Lucas, G. M., Rodriguez, A. E., Bielavitz, S., Fanucchi, L. C., Hoffman, K. A., Bachrach, K., Payne, E. H., Collins, J. A., Matthews, A., Oden, N., Jacobs, P., Jelstrom, E., Sorensen, J. L., and McCarty, D., HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial., Addiction, 2022.
Y. - I. Hser, Evans, E., Huang, D., Weiss, R., Saxon, A., Carroll, K. M., Woody, G., Liu, D., Wakim, P., Matthews, A. G., Hatch-Maillette, M., Jelstrom, E., Wiest, K., McLaughlin, P., and Ling, W., Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial., Addiction, vol. 111, no. 4, pp. 695-705, 2016.
J. Gryczynski, McNeely, J., Wu, L. - T., Subramaniam, G. A., Svikis, D. S., Cathers, L. A., Sharma, G., King, J., Jelstrom, E., Nordeck, C. D., Sharma, A., Mitchell, S. G., O'Grady, K. E., and Schwartz, R. P., Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care., J Gen Intern Med, vol. 32, no. 9, pp. 990-996, 2017.